Analyst firms · Guggenheim · IMCR

Guggenheim IMCR price target and rating history

Immunocore Holdings plc (IMCR) · Health Care

Guggenheim rates Immunocore Holdings plc (IMCR) Neutral with a $85 price target, as of its latest action on Sep 18, 2025. It has published 3 rating actions on IMCR since March 2023, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$85
Median target, all firms
Too few
Actions on IMCR
3

Every Guggenheim rating on IMCR

How other firms rate IMCR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesHold$33Mar 16, 2026
UBSBuy$55Jan 7, 2026

Questions about Guggenheim and IMCR

What is Guggenheim's price target for IMCR?
Guggenheim's latest stated price target for Immunocore Holdings plc (IMCR) is $85, from its action on Mar 30, 2023.
What is Guggenheim's rating on IMCR?
Guggenheim rates IMCR Neutral, a neutral rating, as of Sep 18, 2025.
When did Guggenheim last change its view on IMCR?
On Sep 18, 2025, Guggenheim resumes coverage at Neutral.

All Guggenheim ratingsIMCR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.